Psychiatry
1 drug is in development for Generalized Anxiety Disorder.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Generalized Anxiety Disorder pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| dt120 | Definium Therapeutics Inc. (DFTX) |
About this indication
Generalized Anxiety Disorder context
Psychiatry·MeSH: Generalized Anxiety Disorder (D000098647)
Also known as: Anxieties, Generalized, Anxiety Disorder, General, Anxiety Disorders, General, Anxiety Disorders, Generalized, Anxiety, Generalized
Prevalence
6090.6 / 100K
Incidence
716.2 / 100K/yr
Frequently asked questions
How many drugs are in development for Generalized Anxiety Disorder?
BioSniper tracks 1 drug in development for Generalized Anxiety Disorder across 1 company.
How many clinical trials target Generalized Anxiety Disorder?
There are 7 clinical trials targeting Generalized Anxiety Disorder tracked by BioSniper.
What is the prevalence of Generalized Anxiety Disorder?
The estimated prevalence of Generalized Anxiety Disorder is approximately 6090.6 per 100,000 population.